Curocellbtx
4 known investors
Curocell develops gene-engineered immune cell (CAR-T) cancer therapies, producing advanced medicines in its own GMP facilities. Its lead product, Limkato, is an approved CAR-T anti-cancer drug aimed at treating various cancers.
BiotechHealthtech
Investors · 4
Frequently asked questions
- What does Curocellbtx do?
- Curocell develops gene-engineered immune cell (CAR-T) cancer therapies, producing advanced medicines in its own GMP facilities. Its lead product, Limkato, is an approved CAR-T anti-cancer drug aimed at treating various cancers.
- Who are Curocellbtx's investors?
- Curocellbtx's investors include Aju IB Invesment Corporation, Atinum Investment Co. Ltd., IMM Investment Japan, LB Investment.